Medtronic plc (MDT) Net Profit Margin: 13.20%
Is Medtronic plc’s net profit margin high or low?
Medtronic plc's net profit margin of 13.20% is in line with its 5-year average of 13.06%, around the middle of its 5-year range (11.36%–15.90%).
The net profit margin for Medtronic plc (MDT) is 13.20% as of Wednesday, June 10, 2026. It is below its 12-month average by 2.58% (13.55%).
MDT Net Profit Margin Chart
MDT Average Net Profit Margin Chart
MDT Current vs Average Net Profit Margin Chart
MDT Net Profit Margin Metrics
NET PROFIT MARGIN
13.20%
NET PROFIT MARGIN AVG TTM
13.55%
NET PROFIT MARGIN AVG 3Y
12.62%
NET PROFIT MARGIN AVG 5Y
13.06%
NET PROFIT MARGIN AVG 10Y
13.30%
NET PROFIT MARGIN AVG 15Y
15.01%
NET PROFIT MARGIN AVG 20Y
16.02%
CURRENT VS TTM AVG
-2.58%
CURRENT VS 3Y AVG
+4.58%
CURRENT VS 5Y AVG
+1.07%
CURRENT VS 10Y AVG
-0.73%
CURRENT VS 15Y AVG
-12.06%
CURRENT VS 20Y AVG
-17.61%
MDT Competitors' Net Profit Margin
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Medtronic plc (MDT) | $103.04B | 13.20% | 13.55% | 12.62% | 13.06% |
| Vertex Pharmaceuticals Incorporated (VRTX) | $110.77B | 35.40% | 13.94% | 25.44% | 29.40% |
| Bristol-Myers Squibb Company (BMY) | $114.14B | 15.01% | -1.95% | 6.91% | 3.59% |
| Elevance Health Inc. (ELV) | $87.43B | 2.62% | 3.11% | 3.37% | 3.60% |
| CVS Health Corporation (CVS) | $125.16B | 0.72% | 0.84% | 1.34% | 1.79% |
| Cigna Corporation (CI) | $78.25B | 2.26% | 1.78% | 2.48% | 3.04% |
| Danaher Corporation (DHR) | $130.25B | 14.89% | 15.52% | 19.51% | 19.37% |
| Regeneron Pharmaceuticals, Inc. (REGN) | $62.59B | 29.65% | 31.24% | 32.06% | 36.64% |
| Pfizer Inc. (PFE) | $146.36B | 11.83% | 12.51% | 14.97% | 18.18% |
| Intuitive Surgical, Inc. (ISRG) | $146.44B | 28.15% | 28.09% | 25.67% | 26.14% |
Margin Comparison
Operating Margin
17.8%
Net Profit Margin
13.2%
Medtronic plc Net Profit Margin Formula & Definition
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Medtronic plc Net Profit Margin FAQ
- What is the net profit margin for Medtronic plc (MDT)?
- The net profit margin for MDT stock is 13.20%.
- Is Medtronic plc's net profit margin high or low?
- Medtronic plc's net profit margin of 13.20% is in line with its 5-year average of 13.06%, around the middle of its 5-year range (11.36%–15.90%).
- What is the TTM average net profit margin for Medtronic plc (MDT)?
- The TTM average net profit margin for MDT stock is 13.55%.
- What is the 3Y average net profit margin for Medtronic plc (MDT)?
- The 3Y average net profit margin for MDT stock is 12.62%.
- What is the 5Y average net profit margin for Medtronic plc (MDT)?
- The 5Y average net profit margin for MDT stock is 13.06%.
- What is the 10Y average net profit margin for Medtronic plc (MDT)?
- The 10Y average net profit margin for MDT stock is 13.30%.
- What is the 15Y average net profit margin for Medtronic plc (MDT)?
- The 15Y average net profit margin for MDT stock is 15.01%.
- What is the 20Y average net profit margin for Medtronic plc (MDT)?
- The 20Y average net profit margin for MDT stock is 16.02%.
Medtronic plc Net Profit Margin History
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-04-24 | 13.20% |
| 2025-04-25 | 13.90% |
| 2024-04-26 | 11.36% |
| 2023-04-28 | 12.03% |
| 2022-04-29 | 15.90% |
| 2021-04-30 | 11.97% |
| 2020-04-24 | 16.56% |
| 2019-04-30 | 15.16% |
| 2018-04-30 | 10.36% |
| 2017-04-30 | 13.56% |
| 2016-04-30 | 12.27% |
| 2015-04-30 | 13.20% |
| 2014-04-30 | 18.02% |
| 2013-04-30 | 20.90% |
| 2012-04-30 | 22.35% |
| 2011-04-30 | 19.43% |
| 2010-04-30 | 19.59% |
| 2009-04-30 | 14.86% |
| 2008-04-30 | 16.51% |
| 2007-04-30 | 22.78% |
| 2006-04-30 | 22.55% |
| 2005-04-30 | 17.94% |
| 2004-04-30 | 21.56% |
| 2003-04-30 | 20.87% |
| 2002-04-30 | 15.35% |
| 2001-04-30 | 18.84% |
| 2000-04-30 | 21.91% |
| 1999-04-30 | 11.33% |
| 1998-04-30 | 22.83% |
| 1997-04-30 | 23.92% |
Related Metrics
About Medtronic plc
Medtronic plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies. These solutions serve healthcare systems, clinicians, physicians, and patients across the world. The company's operations are categorized into several key portfolios: Cardiovascular Portfolio: This segment focuses on cardiac health, providing technologies for heart rhythm management, including implantable pacemakers, defibrillators, and monitoring systems, alongside cardiac ablation tools and remote patient software. It also addresses structural heart issues with products like aortic and pulmonary valves, surgical repair devices, and endovascular stent grafts, in addition to offerings for percutaneous coronary interventions (e.g., angioplasty balloons). Medical Surgical Portfolio: Offering a broad spectrum of surgical instruments and therapies, this division includes staples, vessel sealing devices, wound closure products, and electrosurgical equipment. It also pioneers surgical artificial intelligence and robotic-assisted platforms, alongside solutions for hernia repair, gynecology, lung conditions, minimally invasive gastrointestinal and hepatologic diagnostics, patient monitoring, airway management, ventilation therapies, and renal disease. Neuroscience Portfolio: This division delivers specialized products for a diverse group of medical professionals, such as spinal surgeons, neurosurgeons, neurologists, pain management specialists, and ENT experts. Its offerings span energy surgical instruments, advanced image-guided and intra-operative imaging systems, robotic guidance for spine procedures, and therapies targeting the brain's vasculature. Diabetes Operating Unit: Dedicated to diabetes management, this unit provides innovative solutions like insulin pumps and their associated consumables, continuous glucose monitoring (CGM) systems, and smart insulin pen technologies. Established in 1949, Medtronic plc maintains its corporate headquarters in Dublin, Ireland.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Geoffrey Straub Martha